Stool Softener Laxative Capsule, Liquid Filled
NDC Package 17856-7281-9
Package Information
Stool Softener Laxative (docusate sodium) capsules is adults and children 12 years of age and over: take 1 softgel daily or as directed by a doctorchildren under 12 years of age: ask a doctor. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-7281 and is authorized under FDA application M.
Identification & Billing
- RxCUI: 1245468 - docusate sodium 250 MG Oral Capsule
- RxCUI: 1245468 - DOSS Sodium 250 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-7281 - Stool Softener Laxative
- 17856-7281-9 - 99 POUCH in 1 BOX, UNIT-DOSE / 1 CAPSULE, LIQUID FILLED in 1 POUCH
- 17856-7281 - Stool Softener Laxative
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (17856-7281). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-7281-9 identifies a specific commercial package of 99 pouch in 1 box, unit-dose / 1 capsule, liquid filled in 1 pouch of Stool Softener Laxative, a human over the counter drug labeled by Atlantic Biologicals Corp.. This capsule, liquid filled is formulated for oral use and contains docusate sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on October 14, 2022. The current certification is valid through December 31, 2027.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856728109. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.